Fig. 3. PN1 binds to HtrA1. (A) Overview of FLAG-tagged protein constructs of wild-type PN1, point mutant PN1pm and C-terminal deletion mutant PN1δC. Arrowhead indicates the signal peptide cleavage site and numbers indicate the amino acid position of the reactive center loop (RCL). Plus/minus signs indicate binding to HtrA1 protein. (B) HtrA1 co-immunoprecipitates with FLAG-PN1, and FLAG-PN1 in turn co-immunoprecipitates with HtrA1 in mRNA-injected embryos at stage 17. (C) Overexpressed HtrA1 immunoprecipitates FLAG-PN1pm less efficiently than FLAG-PN1 and fails to immunoprecipitate FLAG-PN1δC in embryos at stage 10.5. (D) Overview of wild-type and mutant HtrA1 protein constructs. Plus/minus signs indicate binding to PN1 protein. SP, signal peptide; IB, IGF-binding domain; K, kazal-type serine protease inhibitor domain; Trypsin, trypsin-like serine protease domain; PDZ, PSD95/DLG1/ZO1 domain. The region recognized by HtrA1 antibody is indicated. (E) All indicated HtrA1 constructs, except HtrA1δTry, immunoprecipitate FLAG-PN1 at similar levels in embryos at stage 11. (F) Model of PN1-HtrA1 interaction. The trypsin domain of HtrA1 binds to the RCL-containing C-terminus of PN1. (B,C,E) mRNA amounts were: HtrA1-derived, 100 pg; PN1-derived, 300 pg.
Image published in: Acosta H et al. (2015)
Copyright © 2015. Image reproduced with permission of the publisher and the copyright holder. This is an Open Access article distributed under the terms of the Creative Commons Attribution License.
Permanent Image Page
Printer Friendly View
XB-IMG-147734